Soluble form of CTLA-4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients.

Cancer Med · 2022 · PMC9582685 · PMID 35435327

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The analyses of sCTLA‐4 and clinical parameters confirmed that sCTLA‐4 level were negatively correlated with antiviral therapy, although this did not reach statistical significance in the current study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.